Axol Bioscience acquires Phenocell to advance human disease models 21 Oct Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous DeepHealth Strengthens AI Breast Cancer Screening Position with Kheiron Acquisition Next Next 10 Cambridge spinouts changing the story of cancer
Axol Bioscience acquires Phenocell to advance human disease models 21 Oct Written by Alexandra Collingbourne Alexandra Collingbourne